Knowledge and attitude toward postoperative antithrombotic management and prevention in patients with coronary

Chunlu Liu1, Haijun Zhang1, Liming Yang2

  • 1Department of Cardiology, Kailuan General Hospital, Tangshan, China.

Insights

Coronary artery disease patients undergoing revascularization show poor knowledge but favorable attitudes towards antithrombotic management. Targeted education is crucial for improving patient compliance and cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Patient Education

Background:

  • Postoperative antithrombotic management is critical for patients with coronary artery disease (CAD) after revascularization.
  • Understanding patient knowledge and attitudes is essential for optimizing treatment adherence and clinical outcomes.

Purpose of the Study:

  • To explore the knowledge and attitudes (KA) of CAD patients regarding postoperative antithrombotic management and prevention following coronary revascularization.

Main Methods:

  • A cross-sectional study was conducted with 523 CAD outpatients and inpatients.
  • Data on demographic characteristics and KA scores were collected using a self-made questionnaire.

Main Results:

  • Patients exhibited poor knowledge (mean score: 13.20 ± 6.20) but favorable attitudes (mean score: 43.68 ± 6.01) toward antithrombotic management.
  • Lower education levels and higher income were associated with better knowledge.
  • Knowledge, BMI, education level, income, hypertension, and blood test frequency influenced patient attitudes.

Conclusions:

  • CAD patients require enhanced education on postoperative antithrombotic strategies.
  • Interventions should target individuals with lower educational attainment and income to improve understanding and adherence.
  • Improved patient knowledge is vital for better compliance and enhanced cardiovascular health post-revascularization.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
519
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
167
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
288
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
489